Michael L. Meyers
2016
In 2016, Michael L. Meyers earned a total compensation of $550.8K as Chief Medical Officer at Syndax Pharmaceuticals, a 61% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $152,500 |
|---|---|
| Salary | $378,750 |
| Other | $19,564 |
| Total | $550,814 |
Meyers received $378.8K in salary, accounting for 69% of the total pay in 2016.
Meyers also received $152.5K in non-equity incentive plan and $19.6K in other compensation.
Rankings
In 2016, Michael L. Meyers' compensation ranked 10,835th out of 14,075 executives tracked by ExecPay. In other words, Meyers earned more than 23.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,835 out of 14,075 | 23rd |
Division Manufacturing | 4,213 out of 5,486 | 23rd |
Major group Chemicals And Allied Products | 1,504 out of 1,900 | 21st |
Industry group Drugs | 1,210 out of 1,543 | 22nd |
Industry Pharmaceutical Preparations | 943 out of 1,173 | 20th |
Source: SEC filing on April 10, 2018.
Meyers' colleagues
We found two more compensation records of executives who worked with Michael L. Meyers at Syndax Pharmaceuticals in 2016.